Program-veilig -

Challenging the Current Paradigm for ADA Testing

21-22 September 2023, NH Málaga, Spain

The ‘W4’ of Metabolite profiling and quantification strategies in drug R&D:

When, What, Why and Who?

The program can also be downloaded as a pdf.

24 September 2015
17:00 –	20:00	Registration desk opens
25 September 2015
07.30 –	09.00	Registration desk opens
09.00 –	09.05	Welcome and aim of the meeting
09.05 –	09.30	Scientific and regulatory environment in metabolite profiling and quantification today
		(presenter: from EBF), including FB from EBF Survey
09.30 –	09.55	Preceding scientific drivers and tools to influence metabolic profiling in the regulatory space
		(presenter: Claude Delatour, UCB BioPharma)
09.55 –	10.20	Current practices and future vision on metabolite profiling and quantification in Boehringer-Ingelheim
		(presenter: Stefan Blech, Boehringer-Ingelheim)
10.20 –	10.50	Coffee break
10.50 –	11.15	Current practices and future vision on metabolite profiling and quantification in GlaxoSmithKline
		(presenter: Graeme Young, GlaxoSmithKline)
11.15 –	11.40	Current practices and future vision on metabolite profiling and quantification in Janssen R&D
		(presenter: Geert Mannens, Janssen R&D)
11.40 –	12.10	*How to manage metabolite profiling requests from a CRO perspective?*
		(presenter: *Chris Lowrie, Charles River)*
12.10 –	13.00	Lunch
13.00 –	15.00	*Workshop: towards best practice*
13:00 –	13.30	– A ‘best practice’ starting proposal (EBF presenter)
13:30 –	15:00	– workshop discussion including multi stakeholder input
		*(Moderators: presenters from morning sessions)*
15.00 –	15.30	Coffee break
15.30 –	16.30	*Summary, conclusion and next steps*
16:30		Adjourn

__________________________________________________________________________________

Meeting Organisation

Stefan Blech, Boehringer Ingelheim – John Smeraglia, UCB – Steve White, GlaxoSmithKline – Stephen Williams, CRL – Stuart McDougall, Covance – Philip Timmerman, Janssen R&D

The conference is organised as a non-sponsored non-profit event by European Bioanalysis Forum VZW